Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Reichen

Showing results (171-180 of 187) with videos related to

Pageof 19
Sort By:
Molecular Immunology|December 14, 2001
Peptide vaccines against hepatitis B virus: from animal model to human studiesO B Engler, W J Dai, A Sette, et al.
Hepatology (Baltimore, Md.)|July 1, 1988
Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertensionM Navasa, J Bosch, J Reichen, et al.
Langenbeck'S Archives of Surgery|August 7, 1999
Primary liver disease as a determinant for acute rejection after liver transplantationC A Seiler, J F Dufour, E L Renner, et al.
Journal of Drug Targeting|October 15, 1998
Targeting of naproxen covalently linked to HSA to sinusoidal cell types of the liverB N Melgert, E Wartna, C Lebbe, et al.
Hepatology (Baltimore, Md.)|May 1, 1997
Ectopic expression of the calcium-binding protein parvalbumin in mouse liver endothelial cellsM B Castillo, M W Berchtold, T Rülicke, et al.
Gut|March 15, 2001
Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factorsR Issa, E Williams, N Trim, et al.
Academic Radiology|January 1, 1997
Dynamic phosphorus-31 spectroscopy after fructose load in experimental biliary liver cirrhosisJ P Vallée, E Hiltbrand, H Zimmermann, et al.
European Journal of Clinical Investigation|March 19, 2003
Portal hypertension is associated with increased mRNA levels of vasopressor G-protein-coupled receptors in human hepatic arteriesM Neef, E Biecker, J Heller, et al.
Zeitschrift Fur Gastroenterologie. Verhandlungsband|April 1, 1988
[The "Liver" Study Group: portal hypertension]J Reichen, J Bosch, M Staritz, et al.
Liver|June 26, 2001
Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patientsA B van Nunen, M Baumann, M P Manns, et al.
Pageof 19

Showing results (171-180 of 187) with videos related to

Sort By:
Pageof 19
Molecular Immunology|December 14, 2001
Peptide vaccines against hepatitis B virus: from animal model to human studiesO B Engler, W J Dai, A Sette, et al.
Hepatology (Baltimore, Md.)|July 1, 1988
Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertensionM Navasa, J Bosch, J Reichen, et al.
Langenbeck'S Archives of Surgery|August 7, 1999
Primary liver disease as a determinant for acute rejection after liver transplantationC A Seiler, J F Dufour, E L Renner, et al.
Journal of Drug Targeting|October 15, 1998
Targeting of naproxen covalently linked to HSA to sinusoidal cell types of the liverB N Melgert, E Wartna, C Lebbe, et al.
Hepatology (Baltimore, Md.)|May 1, 1997
Ectopic expression of the calcium-binding protein parvalbumin in mouse liver endothelial cellsM B Castillo, M W Berchtold, T Rülicke, et al.
Gut|March 15, 2001
Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factorsR Issa, E Williams, N Trim, et al.
Academic Radiology|January 1, 1997
Dynamic phosphorus-31 spectroscopy after fructose load in experimental biliary liver cirrhosisJ P Vallée, E Hiltbrand, H Zimmermann, et al.
European Journal of Clinical Investigation|March 19, 2003
Portal hypertension is associated with increased mRNA levels of vasopressor G-protein-coupled receptors in human hepatic arteriesM Neef, E Biecker, J Heller, et al.
Zeitschrift Fur Gastroenterologie. Verhandlungsband|April 1, 1988
[The "Liver" Study Group: portal hypertension]J Reichen, J Bosch, M Staritz, et al.
Liver|June 26, 2001
Efficacy and safety of an intravenous monoclonal anti-HBs in chronic hepatitis B patientsA B van Nunen, M Baumann, M P Manns, et al.
Pageof 19